Shanghai Pharmaceuticals Holding Co. Ltd. Class ASSE: 601607

Announcement on Approval of Eslicarbazepine Acetate Tablets by the U.S. FDA

· Issued by Shanghai Pharmaceuticals Holding Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Approval of Eslicarbazepine Acetate Tablets by the U.S. FDA

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment